Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronarysyndromes
S. Sugiyama et al., Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronarysyndromes, AM J PATH, 158(3), 2001, pp. 879-891
Citations number
56
Categorie Soggetti
Research/Laboratory Medicine & Medical Tecnology","Medical Research Diagnosis & Treatment
Inflammation and oxidative stress contribute to the pathogenesis of many hu
man diseases including atherosclerosis. Advanced human atheroma contains hi
gh levels of the enzyme myeloperoxidase that produces the pro-oxidant speci
es, hypochlorous acid (HOCl). This study documents increased numbers of mye
loperoxidase-expressing macrophages in eroded or ruptured plaques causing a
cute coronary syndromes. In contrast, macrophages in human fatty streaks co
ntain little or no myeloperoxidase. Granulocyte macrophage colony-stimulati
ng factor, but not macrophage colony-stimulating factor, selectively regula
tes the ability of macrophages to express myeloperoxidase and produce HOCL
in vitro. Moreover, myeloperoxidase-positive macrophages in plaques co-loca
lized with granulocyte macrophage colony-stimulating factor. Pro-inflammato
ry stimuli known to be present in human atherosclerotic plaque, including C
D40 ligand, lysophosphatidylcholine, or cholesterol crystals, could induce
release of myeloperoxidase from HOCl production by macrophages in vitro. HO
Cl-modified proteins accumulated at ruptured or eroded sites of human coron
ary atheroma. These results identify granulocyte macrophage colony-stimulat
ing factor as an endogenous regulator of macrophage myeloperoxidase express
ion in human atherosclerosis and support a particular role for the myeloper
oxidase-expressing macrophages in atheroma complication and the acute coron
ary syndromes.